2006 Heart-Brain summit proceedings

New paradigms in heart-brain medicine: Nonlinear physiology, state-dependent proteomics

James E. Skinner, PhD

Vicor Technologies, Inc.
Boca Raton, FL
jskinner@vicortech.com

ARTICLE INTRODUCTION

Two pivotal studies using a conscious pig model of heart attack suggest new paradigms for the discovery of cardiac devices and drugs. The first study showed that nonlinear analysis of heartbeat intervals, which are controlled by the nervous system, could predict with high sensitivity and specificity whether or not ventricular fibrillation (VF) would later occur following occlusion (90% reduction of blood flow by pulsed-Doppler recording) of the left anterior descending coronary artery. This predictive ability was later confirmed by retrospective data from humans exhibiting coronary artery narrowing and nonsustained ventricular tachycardia. The second pivotal study showed that the state-dependent release of a salutary molecule during rapid eye movement (REM) sleep would suppress arrhythmogenesis in the acutely infarcted heart. It is presumed that neurosecretion explains the salutary effect, as the latency is on the order of seconds.

This article reports previously patented data from additional investigations by me and my colleagues to further explore these two new paradigms in heart-brain medicine. First I review results from a prospective multicenter study of heartbeat analysis using a nonlinear algorithm to predict future arrhythmic death in emergency room patients. Then I discuss insights from state-dependent proteomics in the hibernating woodchuck and resulting efforts to isolate, identify, and synthesize an anti-infarction molecule from the woodchuck and test its efficacy using bioassay models.

CITATIONS

  1. Skinner JE, Carpeggiani C, Landisman CE, Fulton KW.
    Correlation dimension of heartbeat intervals is reduced in conscious pigs by myocardial ischemia. Circ Res 1991; 68:966–976.
    http://www.ncbi.nlm.nih.gov/pubmed/2009617

  2. Skinner JE, Pratt CM, Vybiral T.
    A reduction in the correlation dimension of heartbeat intervals precedes imminent ventricular fibrillation in human subjects. Am Heart J 1993; 125:731–743.
    http://www.ncbi.nlm.nih.gov/pubmed/7679868
  3. Skinner JE, Mohr DN, Kellaway P.
    Sleep-stage regulation of ventricular arrhythmias in the unanesthetized pig. Circ Res 1975; 37:342–349.
    http://www.ncbi.nlm.nih.gov/pubmed/168987
  4. Skinner JE.
    PD2i electrophysiological analyzer. US patent 5 720 294. 1998.
  5. Skinner JE.
    PD2i electrophysiological analyzer. US patent 5 709 214. 1998.
  6. Skinner JE.
    Method and system for detecting and/or predicting biological anomalies. US patent 0 147 815. 2004.
  7. Lee TH, Juarez G, Cook EF, et al.
    Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk. N Engl J Med 1991; 324:1239–1246.
    http://www.ncbi.nlm.nih.gov/pubmed/2014037
  8. Hinkle LE Jr, Thaler HT.
    Clinical classification of cardiac death. Circulation 1982; 65:457–464.
    http://www.ncbi.nlm.nih.gov/pubmed/7055867
  9. Skinner JE, Meyer M, Nester BA, et al.
    Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear analysis of RR-intervals. Submitted to Ann Emerg Med; 2006.
  10. Meyer M, Marconi C, Ferretti G, Fiocchi R, Cerretelli P, Skinner JE.
    Heart rate variability in the human transplanted heart: nonlinear dynamics and QT vs RR-QT alterations during exercise suggest a return of neurocardiac regulation in long-term recovery. Integr Physiol Behav Sci 1996; 31:289–305.
    http://www.ncbi.nlm.nih.gov/pubmed/8982761
  11. Nearing BD, Verrier RL.
    Analysis of complex T-wave oscillations for prediction of ventricular fibrillation. J Electrocardiol 2003; 36(Suppl):199–203.
    http://www.ncbi.nlm.nih.gov/pubmed/14716634
  12. Winfree AT.
    Electrical instability in cardiac muscle: phase singularities and rotors. J Theor Biol 1989; 138:353–405.
    http://www.ncbi.nlm.nih.gov/pubmed/2593680
  13. Centers for Medicare and Medicaid. Proposed decision memo for implantable defibrillators (CAG-00157R3), 2005.
  14. Skinner JE, Anchin JM.
    Anti-infarction molecules. US patent 0 228 371.2003